Pathology
National Institute Details Research in Pathology
Published in Cancer Weekly, January 24th, 2012
2012 JAN 24 -- Research findings, "Inflammatory breast cancer-comparing the effectivity of preoperative docetaxel-epirubicine protocol to conventional antracycline-containing chemotherapy to achieve clinical benefit and complete pathological response," are discussed in a new report. "Our retrospective analysis compared the effectiveness of conventional antracycline-containing protocols (A+) and docetaxel/epirubicine (TE) as primary systemic chemotherapies (PSCT) for inflammatory breast cancer (IBC). Seventy IBC patients received either A'+'(n'='48) or TE (n'='22) as PSCT," scientists writing in the journal Pathology Oncology Research report.
"The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2012-01-24)
More Articles from Cancer Weekly
- Familial Cancer
Study Results from University of Melbourne Update Understanding of Familial Cancer - Translational Medicine
Study Data from University of Colorado Update Understanding of Translational Medicine - Lung Cancer
Study Results from Chinese University of Hong Kong Provide New Insights into Lung Cancer - Bowel Diseases
Studies in the Area of Bowel Diseases Reported from Cedars-Sinai Medical Center - Gastric Cancer
Studies from Yokohama City University Update Current Data on Gastric Cancer - Leukemia
Studies from University of Bari Reveal New Findings on Leukemia - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
